Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-02-18, Stock:LLY, The news for the past five days is as follows:
2021-02-10: NEWS1: IPO Stock Returns Bullish Gains After Lilly-Partnered Covid Drug Nabs OK.NEWS2: Coronavirus update: CDC endorses double-masking as COVID vaccine push continues.NEWS3: WHO Recommends Use of AstraZeneca Vaccine Against Variants.NEWS4: Lilly (LLY) COVID-19 Antibody Combo Gets FDA's Emergency Nod.NEWS5: TikTok Sale to Oracle, Walmart Called Off Indefinitely.NEWS6: IPO Stock AbCellera Nears Breakout After Lilly-Partnered Covid Drug Nabs OK.NEWS7: FDA grants authorization to Lilly's COVID-19 antibody treatment.NEWS8: Eli Lilly Doesn't Plan To Claw Back Past Pay From Former CFO - WSJ.NEWS9: The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs.NEWS10: Eli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency Approval.NEWS11: Etesevimab (JS016) Administered with Bamlanivimab Receives FDA Emergency Use Authorization for COVID-19.NEWS12: REFILE-UPDATE 1-Eli Lilly's antibody combination receives FDA emergency use authorization for COVID-19.NEWS13: Lilly's bamlanivimab (LY-CoV555) administered with etesevimab (LY-CoV016) receives FDA emergency use authorization for COVID-19.
2021-02-11: NEWS1: Lilly To Participate in SVB Leerink Global Healthcare Conference.
2021-02-12: NEWS1: Eli Lilly Keeps Piling Up Share Price Gains.NEWS2: Eli Lilly Executives Enthusiastic About Alzheimer’s Drug, Analyst Says.NEWS3: Can Coronavirus Antibodies Overcome Their Obstacles?.NEWS4: Pharma Stock Roundup: AZN's Q4 Earnings, FDA Approval for LLY & SNY's Drugs.
2021-02-16: nan
2021-02-17: NEWS1: Vir and GSK Will Collaborate on Flu Therapy.NEWS2: Eli Lilly's Tirzepatide Reduces A1C And Body Weight, Late-Stage Studies In Type 2 Diabetes Show.NEWS3: Tirzepatide significantly reduced A1C and body weight in people with type 2 diabetes in two phase 3 trials from Lilly's SURPASS program.NEWS4: Kimberly H. Johnson Elected to Lilly Board of Directors.

Answer: Decrease